These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9286176)

  • 1. Images in neuroscience. Alzheimer's disease: from genes to pathogenesis.
    Selkoe DJ
    Am J Psychiatry; 1997 Sep; 154(9):1198. PubMed ID: 9286176
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological transgenic mouse models of Alzheimer's disease.
    Crews L; Rockenstein E; Masliah E
    Handb Clin Neurol; 2008; 89():291-301. PubMed ID: 18631753
    [No Abstract]   [Full Text] [Related]  

  • 3. Single point mutations induce a switch in the molecular mechanism of the aggregation of the Alzheimer's disease associated Aβ42 peptide.
    Bolognesi B; Cohen SI; Aran Terol P; Esbjörner EK; Giorgetti S; Mossuto MF; Natalello A; Brorsson AC; Knowles TP; Dobson CM; Luheshi LM
    ACS Chem Biol; 2014 Feb; 9(2):378-82. PubMed ID: 24199868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's research moves to mice.
    Marx J
    Science; 1991 Jul; 253(5017):266-7. PubMed ID: 1907022
    [No Abstract]   [Full Text] [Related]  

  • 5. Animal models of Alzheimer's disease.
    Higgins LS
    Mol Med Today; 1999 Jun; 5(6):274-6. PubMed ID: 10475711
    [No Abstract]   [Full Text] [Related]  

  • 6. Making models for Alzheimer's disease.
    Lamb BT
    Nat Genet; 1995 Jan; 9(1):4-6. PubMed ID: 7704022
    [No Abstract]   [Full Text] [Related]  

  • 7. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.
    Robb E; Perez K; Hung LW; Masters CL; Barnham KJ; Cherny RA; Bush AI; Adlard PA; Finkelstein DI
    J Alzheimers Dis; 2015; 44(1):69-78. PubMed ID: 25182735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular biology of Alzheimer's disease and animal models.
    Price DL; Sisodia SS
    Annu Rev Med; 1994; 45():435-46. PubMed ID: 8198393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 is critical for the propagation of β-amyloid protein and reducing the glycosylation of tau in Alzheimer's disease.
    Guan PP; Yu X; Zou YH; Wang P
    Cell Mol Immunol; 2019 Nov; 16(11):892-894. PubMed ID: 31551514
    [No Abstract]   [Full Text] [Related]  

  • 11. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in mice.
    Xie K; Liu Y; Hao W; Walter S; Penke B; Hartmann T; Schachner M; Fassbender K
    Neurobiol Aging; 2013 Oct; 34(10):2389-98. PubMed ID: 23673309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the triggers, progression, and effects of Alzheimer's disease.
    Medeiros R; Chabrier MA; LaFerla FM
    J Alzheimers Dis; 2013; 33 Suppl 1():S195-210. PubMed ID: 22635105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease.
    van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF
    Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization.
    Hamley IW
    Chem Rev; 2012 Oct; 112(10):5147-92. PubMed ID: 22813427
    [No Abstract]   [Full Text] [Related]  

  • 16. A potential function for neuronal exosomes: sequestering intracerebral amyloid-β peptide.
    Yuyama K; Sun H; Usuki S; Sakai S; Hanamatsu H; Mioka T; Kimura N; Okada M; Tahara H; Furukawa J; Fujitani N; Shinohara Y; Igarashi Y
    FEBS Lett; 2015 Jan; 589(1):84-8. PubMed ID: 25436414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of amyloid beta-protein in Alzheimer's disease.
    Liddell M; Owen MJ
    Lancet; 1992 Oct; 340(8823):851. PubMed ID: 1357270
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical genetics, IV. Alzheimer's disease: from gene to pathology.
    Jay G
    Am J Psychiatry; 1997 Oct; 154(10):1359. PubMed ID: 9326816
    [No Abstract]   [Full Text] [Related]  

  • 19. Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1).
    Esteras N; Alquézar C; Bartolomé F; Antequera D; Barrios L; Carro E; Cerdán S; Martín-Requero A
    J Alzheimers Dis; 2012; 30(2):337-53. PubMed ID: 22406445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
    Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
    J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.